Application of biomaterials in the development of hydrogel-forming microneedles integrated with a cyclodextrin drug reservoir for improved pharmacokinetic profiles of telmisartan

Cindy Kristina Enggi, Sulistiawati Sulistiawati, Achmad Himawan, Muhammad Raihan, Israini Wiyulanda Iskandar, Rizki Rachmad Saputra, Latifah Rahman, Risfah Yulianty, Marianti A. Manggau, Ryan F. Donelly, Muhammad Aswad, Andi Dian Permana

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Telmisartan (TEL) is a promising antihypertensive agent among other angiotensin receptor blockers. However, its oral application is limited by its poor water solubility. This study presents the successful utilization of biomaterial-based hydrogel-forming microneedles integrated with a direct compressed tablet reservoir (HFMN-DCT) for the transdermal delivery of telmisartan in the treatment of hypertension. The combination of PVP, PVA, and tartaric acid was used in the HFMN formulation. A range of cross-linking temperatures and times were employed to optimize the characteristics of the HFMN. The HFMN exhibited excellent swelling capacity, mechanical strength, and insertion properties. Additionally, the poorly soluble characteristic of TEL was improved by the inclusion complex formulation with β-cyclodextrin (βCD). Phase solubility analysis showed an Ap-type diagram, indicating a higher-order complex between TEL and βCD, with respect to βCD. A ratio of TEL:βCD of 1:4 mM demonstrates the highest solubility enhancement of TEL. The inclusion complex formation was confirmed by FTIR, XRD, DSC, and molecular docking studies. A significantly higher release of TEL (up to 20-fold) from the inclusion complex was observed in the in vitro release study. Subsequently, a DCT reservoir was developed using various concentrations of sodium starch glycolate. Essentially, both the HFMN and DCT reservoir exhibit hemocompatibility and did not induce any skin irritation. The optimized combination of the HFMN-DCT reservoir showed an ex vivo permeation profile of 83.275 ± 2.405%. Notably, the proposed system showed superior pharmacokinetic profiles in the in vivo investigation using male Wistar rats. Overall, this study highlights the potential of HFMN-DCT reservoir systems as a versatile platform for transdermal drug delivery applications.
Original languageEnglish
Pages (from-to)1554–1576
JournalACS Biomaterials Science and Engineering
Volume10
Issue number3
Early online date26 Feb 2024
DOIs
Publication statusPublished - 11 Mar 2024

Keywords

  • Biomedical Engineering
  • Biomaterials

Fingerprint

Dive into the research topics of 'Application of biomaterials in the development of hydrogel-forming microneedles integrated with a cyclodextrin drug reservoir for improved pharmacokinetic profiles of telmisartan'. Together they form a unique fingerprint.

Cite this